Assessment of Coronary Artery Disease by Hybrid PET/CT



Status:Completed
Conditions:Peripheral Vascular Disease, Cardiology
Therapuetic Areas:Cardiology / Vascular Diseases
Healthy:No
Age Range:18 - Any
Updated:10/14/2017
Start Date:March 2006
End Date:April 2008

Use our guide to learn which trials are right for you!

Assessment of Coronary Flow Reserve and CT Angiography By Hybrid PET/CT: Relation to Clinically Indicated SPECT Studies

There have been many advances in the test used to look for heart disease. An example of this
newer technology is the Multislice CT scan (MSCT) and Positron Emission Tomography (PET)
scans.

The use of this type of combined scan may show early coronary artery disease or the degree of
damaged heart muscle form a heart attack with a single exam. It may help doctors to know who
might benefit from heart surgery or angioplasty to increase the blood flow to the heart. This
type of detailed images has previously been available only through cardiac catheterization.

Advances in Non-invasive Multislice CT Imaging: Multislice CT (MSCT) and PET imaging are
becoming more widely available and more useful in cardiac assessment. MSCT provides
quantification of coronary calcium as well as information about the structures of the
coronary vessel walls and atherosclerotic plaques. Multiple studies have demonstrated that
MSCT provides information on coronary artery stenosis comparable to that obtained from
invasive coronary angiography. PET imaging provides functional data via the measurement of
coronary flow reserve (CFR). CFR is a quantitative measure of the increase in coronary blood
flow in response to vasodilation; normal coronary flow is able to augment by three- to
four-fold; diseased coronary arteries show less ability to increase flow, i.e. less CFR.
Assessment of CFR yields functional information about the significance of coronary disease
and is often used clinically in conjunction with anatomic imaging to identify early
atherosclerosis. There is no current data evaluating the incremental value of hybrid PET/CT
assessment of CFR and coronary anatomy in relation to SPECT studies in the clinical setting.

Inclusion Criteria:

- Subject must be 18 years of age or older and able to give informed consent.

- Scheduled for clinically indicated gated Adenoscan SPECT studies at the University of
Maryland Medical Center or Baltimore VA Center

- Documentation from participant's health care provider indicating no objection to
subject's participation in study.

Exclusion Criteria:

- Hepatic; thyroid or renal disease (creatinine >1.5 or GFR < 60mL/min)

- Women of childbearing age not using medically acceptable form of contraception,
pregnant or breast-feeding

- Contrast allergy

- Inability to cooperate with imaging
We found this trial at
1
site
22 S Greene St
Baltimore, Maryland 21201
(410) 328-8667
University of Maryland Medical Center Founded in 1823 as the Baltimore Infirmary, the University of...
?
mi
from
Baltimore, MD
Click here to add this to my saved trials